Tag: FDA enforcement

CHC_FDA-Regulatory Images1

10/03/2016

OPDP’s Abrams: Enforcement Still a Priority, Despite Decrease in Letters

CHC_FDA-Regulatory Images1

09/15/2016

OPDP’s Second Enforcement Letter in Two Weeks Targets Investigational Drug

09/08/2016

OPDP Sends Enforcement Letter for Promotion of Investigational Drug

CHC_general1

07/22/2016

OPDP Issues Just Two Enforcement Letters in First Half of 2016

01/25/2016

OPDP Enforcement Letter Cites Hospira for Omission of Risk in YouTube Video

12/16/2015

Pacira Prevails in Exparel Settlement with FDA

09/10/2015

Pacira Files Complaint Calling FDA Marketing Restrictions Unconstitutional

03/12/2015

What Does OPDP’s Enforcement Lull Mean?

05/23/2014

OPDP Enforcement Letters Address Omission of Risk Information